Gestational trophoblastic disease

Obstetrics and Gynecology Clinics of North America

Volumn 28, Issue 4, 2001, Pages 805-817

  Shapter, Anne P ^a   McLellan, Robert ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CHORIONIC GONADOTROPIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; FOLINIC ACID; METHOTREXATE; VINCRISTINE;

BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER STAGING; DRUG INDUCED DISEASE; FEMALE; HIGH RISK PATIENT; HUMAN; HYDATIDIFORM MOLE; HYSTERECTOMY; LIVER METASTASIS; LUNG METASTASIS; METASTASIS; PLACENTA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; TROPHOBLASTIC DISEASE; VAGINA BLEEDING; VAGINA CANCER;

EID: 0035204199     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8545(05)70237-0     Document Type: Article

References (37)

1. Risks and prognostic factors in trophoblastic neoplasia
2. High-risk metastatic trophoblastic disease
3. Immunodiagnosis and monitoring of gonadotropin-producing metastases in the central nervous system
4. Treatment of high-risk choriocarcinoma
5. Risk factors for complete molar pregnancy from a case-control study
6. Management of complete molar pregnancy
7. Natural history of partial molar pregnancy
8. Gestational trophoblastic diseases
9. Pathogenesis of gestational trophoblastic neoplasms
10. Modified triple chemotherapy in the management of high-risk metastatic gestational trophoblastic tumors
11. Subsequent pregnancy outcome in patients with molar pregnancy and gestational trophoblastic tumors
12. Gestational trophoblastic disease: Subsequent pregnancy outcome, including repeat molar pregnancy
13. EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT)
14. Metastatic gestational trophoblastic disease: Experience at the New England Trophoblastic Disease Center, 1965 to 1985
15. Clinical experience with placental-site trophoblastic tumors at the New England Trophoblastic Disease Center
16. Revised FIGO staging system for gestational trophoblastic tumors: Recommendations regarding therapy
17. High-risk metastatic gestational trophoblastic disease: Further stratification into two clinical entities
18. Androgenetic origin of hydatidiform mole
19. Prophylactic chemotherapy for hydatidiform mole: Five to 15 years follow-up
20. Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydafidiform mole
21. A prospective genetic study of complete and partial hydatidiform moles
22. Management of high-risk gestational trophoblastic disease
23. Low-risk metastatic gestational trophoblastic disease
24. Recurrent gestational trophoblastic neoplasia: Experience of the Southeastern Regional Trophoblastic Disease Center
25. Management of placental site trophoblastic tumors
26. Advances in the epidemiology of gestational trophoblastic disease
27. Parental age and risk of complete and partial hydatidiform mole
28. Dietary factors and risk of trophoblastic disease
29. Genesis of 46 XY hydatidiform mole
30. Sonographic findings and clinical correlations in molar pregnancy
31. Pregnancy outcomes after suscessful chemotherapy for choriocarcinoma and invasive mole: Long-term follow-up
32. Surgical therapy for gestational trophoblastic disease
33. The changing clinical presentation of complete molar pregnancy
34. Syndromes of hydatidiform moles - Partial versus complete
35. The clinicopathologic profile of the partial hydatidiform mole
36. Brain metastases of gestational trophoblastic tumor